LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

Go back to LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
Logic Devices Incorporated (NASDAQ: LOGC) Delayed: 7.06 --0 (-0%)
Previous Close $7.06    52 Week High $0.01 
Open $7.06    52 Week Low $0.00 
Day High $7.06    P/E N/A 
Day Low $7.06    EPS $-0.14 
Volume 6,798,955